Skip to main content
OpenTrials
Completed

NCT Number: NCT05213208

Safety of Propofol Sedation ( > 200 mg) for Colonoscopy.

This study examines that the use of >200 mg of propofol sedation enables patients to drive home safely after outpatient colonoscopy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Safety Issues

Age range

20 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Showa Inan General hospital

Komagane, Nagano, 399-4191, Japan

About this study

The hospital policy of routine discharge to normal activity 1 hour after propofol mono-sedation for EGD or colonoscopy was approved by the ethics committee of Showa Inan General Hospital in January, 2004 (http://www.sihp.jp). The investigator' s subsequent experience verified the safety of this discharge policy which was reconfirmed in March 2014. Based on these studies, the upper limit of 200 mg was established for those allowed early discharge and driving to home.

This study examines that the use of >200 mg of propofol sedation enables patients to drive home safely 90-120 minutes after outpatient colonoscopy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • subjects who drive home by theirselves after colonoscopy using propofol sedation (>200 mg)

Exclusion criteria

  • Subjects who received emergency procedures
  • less than 20 years old pregnant American Society of Anesthesiologists (ASA) class III or IV, overweight (body weight >100 kg) allergic to the drugs used or its components (soybeans or eggs).

Treatment and study plan

Propofol

Drug

Using > 200 mg of propofol sedation colonoscopy is performed. 90-120 minutes after colonoscopy subjects go home. Within 1 week patients will be asked about their condition and satisfaction for colonoscopy.

Primary outcomes

  1. Traffic accidents

    Time frame: 1 day

    Number of traffic accidents

Secondary outcomes

  1. Patient satisfaction

    Time frame: 1 day

    Patient satisfaction (bad, 0-good 100%) is asked.

Sponsors and collaborators

Lead sponsor

Showa Inan General Hospital

Other

Registry information

Official study title

Propofol Sedation of More Than 200 mg Enables Patients to Drive Home After Outpatient Colonoscopy Including Colorectal Polypectomy

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Jan 28, 2022
Registry last updated
May 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.